DMN Market Analysis
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- —
- P/S (TTM)
- 84.12
- EV/EBITDA
- 0.53
Profitability & growth
- ROE (TTM)
- 0.0%
- Operating margin
- -6820.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- —
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Damon Inc. Common Stock
Company profileDamon Inc. (Ticker: DMN) is a forward-looking company in the healthcare diagnostics sector, focused on delivering cutting-edge solutions for disease detection and management. The firm harnesses proprietary technologies to produce a diverse array of diagnostic products, emphasizing improved patient outcomes. Positioned strategically to meet the surging demand for reliable and prompt diagnostic tools, Damon Inc. is backed by a vigorous pipeline of R&D initiatives. As the company expands its product lines and enhances its market reach, it aims to solidify its status as a key player in the…
Classification
- Sector
- Consumer Cyclical
- Industry
- Auto Manufacturers
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 704 ALEXANDER STREET, VANCOUVER, BC
- Fiscal year end
- June
- Latest quarter
- Dec 31, 2024
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer